The Aug. 1 post outlined a study in JAMA Internal Medicine that showed that physician management companies with private equity investment led to a rise in prices for anesthesia services for patients.
Anesthesia service prices rose 26 percent for patients who used private equity-backed physician management companies, while prices at companies without private equity investment grew by 12.9 percent from 2012 to 2017.
The post also cited a commentary from AMA President Jack Resneck, MD, published in JAMA Dermatology in which dermatologists reported a loss in physician control after being acquired by private equity firms.
“While investors tout ongoing local decision-making, practices also may lose some control over staffing levels and capital equipment purchases,” Dr. Resneck stated in the commentary.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.